pyrazines has been researched along with Pneumonia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Berber, N; Cagasar, O; Delen, LA; Derya, S; Gok, A; Gok, Z; Kasapoglu, US; Tetik, B | 1 |
| Acar, T; Ari, A; Bozaci, I; Karatas, M; Simsek, C; Tatar, E; Uslu, A; Yildirim, AM; Yildirim, O | 1 |
| Bian, ZR; Che, XW; Liu, XM; Wang, YB; Wu, Q | 1 |
| Bartlett, NL; Beck, JT; Cherfi, A; Cheung, W; Collins, RH; Fan, J; Fanning, SR; Goy, A; Johnston, PB; Kaminski, MS; Kaya, H; Klimovsky, J; Lister, J; O'Connor, OA; Popplewell, LL; Robeva, A; Tuscano, JM; Wang, M; Winter, JN | 1 |
| Ba-Mancini, A; Comenzo, RL; Duh, MS; Gravel, J; Knopf, KB; Lafeuille, MH; Lefebvre, P; Ma, E; Niculescu, L; Shi, H | 1 |
| Abella-Dominicis, E; Barr, PM; Cheson, BD; Di Paolo, J; Dreiling, LK; Friedberg, JW; Greenwald, DR; Hawkins, MJ; He, J; Hu, J; Joshi, A; Lee, H; Liem, AK; Mclntyre, RE; O'Brien, SM; Reddy, A; Saylors, GB; Spurgeon, SE | 1 |
| Li, Z; Tong, J; Wang, Y; Zhu, H | 1 |
| Bartczak, A; Chen, L; Edwards, A; Khattar, R; Levy, G; Liu, MF; Ma, XZ; McGilvray, ID; Zhang, J | 1 |
| Itoh, K; Sasaki, M; Yamaguchi, T | 1 |
| Chisholm, R; Houghton, J; O'Driscoll, BR; O'Riordan, D | 1 |
| Chen, C; Jimenez-Zepeda, VH; Kukreti, V; Reece, DE; Tiedemann, R; Trudel, S | 1 |
| Bonomo, E; Castelfranco, M; Chirico, M; Cova, N; Delmonte, A; Ferrari, A; Franzini, P; Girelli, M; Nocca, G; Pilotti, A; Ratti, G; Scalvini, A; Terruzzi, L | 1 |
1 review(s) available for pyrazines and Pneumonia
| Article | Year |
|---|---|
Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Disease-Free Survival; Hematologic Diseases; Humans; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Proteins; Peripheral Nervous System Diseases; Pneumonia; Proteasome Inhibitors; Pyrazines; Recurrence; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome | 2014 |
2 trial(s) available for pyrazines and Pneumonia
| Article | Year |
|---|---|
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Everolimus; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Middle Aged; Pain; Pneumonia; Pyrazines; Salvage Therapy; Sirolimus; Treatment Outcome | 2014 |
Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Class I Phosphatidylinositol 3-Kinases; Cytokines; Early Termination of Clinical Trials; Female; Humans; Indazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Pneumonia; Protein Kinase Inhibitors; Purines; Pyrazines; Quinazolinones; Salvage Therapy; Syk Kinase | 2016 |
9 other study(ies) available for pyrazines and Pneumonia
| Article | Year |
|---|---|
EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA.
Topics: Aged; Amides; Antimalarials; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Progression; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pneumonia; Pyrazines; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2022 |
Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia.
Topics: Aged; Amides; COVID-19; COVID-19 Drug Treatment; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Kidney Transplantation; Pneumonia; Pyrazines; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
Effects of Ligustrazine on Airway Inflammation in A Mouse Model of Neutrophilic Asthma.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Female; Interleukin-10; Interleukin-17; Leukocyte Count; Lung; Mice, Inbred C57BL; Neutrophils; Pneumonia; Pyrazines; Respiratory Hypersensitivity | 2018 |
Ligustrazine improves blood circulation by suppressing Platelet activation in a rat model of allergic asthma.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Asthma; Blood Circulation; Blood Platelets; Cell Adhesion; Cytokines; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Male; Platelet Activation; Pneumonia; Pyrazines; Rats, Sprague-Dawley | 2016 |
Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome.
Topics: Animals; Blotting, Northern; Blotting, Western; Boronic Acids; Bortezomib; Coronavirus Infections; Cytokines; DNA Primers; Gene Expression Regulation; Histological Techniques; Leupeptins; Lung; Mice; Murine hepatitis virus; Phosphorylation; Pneumonia; Proline; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; STAT Transcription Factors; Survival Analysis; Thiocarbamates; Ubiquitination; Virus Replication | 2010 |
Bortezomib-induced pneumonitis during bortezomib retreatment in multiple myeloma.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Administration Schedule; Humans; Male; Middle Aged; Multiple Myeloma; Pneumonia; Pyrazines; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Breathless on bortezomib.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Male; Middle Aged; Multiple Myeloma; Pneumonia; Pyrazines | 2011 |
Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Muscle Weakness; Neutropenia; Pneumonia; Pyrazines; Recurrence; Retrospective Studies; Thalidomide; Treatment Outcome | 2013 |
[Polycentric clinical trials of new dosage regimens for sulfametopyrazine].
Topics: Aniline Compounds; Bronchitis; Bronchopneumonia; Humans; Pneumonia; Pyrazines | 1970 |